Cholecystitis Bloedwaarden resultaten: wat ze kunnen missen

Categorieën
Artikelen
Gallbladder Health Laboratoriuminterpretatie 2026-update Patiëntvriendelijk

A raised white count, CRP, or liver enzyme can support suspected gallbladder inflammation, but none can diagnose it alone. The more useful question is whether the laboratory pattern fits the pain, examination, and imaging findings.

📖 ~11 minuten 📅
📝 Gepubliceerd: 🩺 Medisch beoordeeld: ✅ Op bewijs gebaseerd
⚡ Beknopte samenvatting v1.0 —
  1. Normale bloedonderzoeken do not rule out acute cholecystitis, especially during the first 6-12 hours of pain or in older adults.
  2. WBC-aantal above 11.0 × 10⁹/L supports an inflammatory process but can remain normal in uncomplicated or early gallbladder inflammation.
  3. CRP above 30 mg/L often adds weight to suspected inflammation, while values above 100 mg/L raise concern for more extensive tissue response.
  4. ALT en AST may rise briefly when a stone passes through the common bile duct; this does not automatically mean primary liver disease.
  5. ALP, GGT, and direct bilirubin are more suggestive of bile-flow obstruction than isolated gallbladder inflammation.
  6. Lipase at least three times the laboratory upper limit suggests acute pancreatitis and changes the urgency and imaging plan.
  7. Echografie is usually the first imaging test when right-upper-abdominal pain suggests gallbladder disease, even if the CBC is normal.
  8. Spoedbeoordeling is needed for fever, jaundice, confusion, persistent vomiting, low blood pressure, or pain lasting more than 6 hours.

What a cholecystitis blood test can and cannot prove

A cholecystitis blood test can show inflammation, altered bile flow, dehydration, or a competing diagnosis; it cannot confirm an inflamed gallbladder by itself. In practice, a normal CBC and liver panel never overrule persistent right-upper-quadrant pain, fever, guarding, or a positive ultrasound finding.

Cholecystitis blood test concept showing a gallbladder cross-section beside laboratory sample analysis
Afbeelding 1: Gallbladder anatomy and laboratory findings must be interpreted as one clinical picture.

Tokyo Guidelines diagnose acute cholecystitis from local symptoms, systemic inflammatory evidence, and confirmatory imaging—not laboratory values alone (Yokoe et al., 2018). A WBC above 11.0 × 10⁹/L, CRP above the local reference limit, or fever can satisfy the systemic component, but ultrasound or another imaging study is still needed for a definite diagnosis.

I have seen patients with severe focal pain after a fatty meal whose WBC was 7.4 × 10⁹/L and whose ALT was entirely normal. Their ultrasound nevertheless showed a stone impacted at the gallbladder neck with wall thickening; early obstruction can be anatomically real before the circulating inflammatory signal has caught up.

Kantesti is een AI-bloedtestanalysator that places CBC, liver-panel, bilirubin, and pancreatic results beside one another rather than treating a single flagged result as a diagnosis. Knowing wat een leverpanel omvat makes it easier to see why normal transaminases do not exclude a gallbladder problem.

How to read the cholecystitis WBC count and differential

A raised neutrophil-predominant WBC count supports acute inflammation but is neither sensitive nor specific for cholecystitis. Many adult laboratories use a total WBC reference interval of roughly 4,0-11,0 × 10⁹/L, although intervals differ by laboratory and age.

Cholecystitis blood test CBC analysis with cellular elements and neutrophil count review
Figuur 2: A CBC can show systemic immune response but cannot locate its source.

A WBC of 12-15 × 10⁹/L with neutrophilia fits uncomplicated acute cholecystitis more comfortably than a normal count, but pneumonia, pyelonephritis, appendicitis, steroid treatment, and even major stress can produce the same pattern. The absolute neutrophil count is more informative than neutrophil percentage when the total WBC is abnormal.

Een WBC boven 18 × 10⁹/L is one factor that can point to severe disease in the Tokyo severity framework, particularly alongside organ dysfunction or a palpable tender mass. It is a triage clue, not a line between “safe” and “unsafe”; someone can deteriorate with a count of 10.5 × 10⁹/L.

Older patients and people taking prednisolone, chemotherapy, or immune-modifying medicines may mount little leukocytosis. Our guide to normal neutrophil counts explains why a result can look numerically ordinary while the clinical situation remains urgent.

Typisch bereik voor volwassenen 4,0-11,0 × 10⁹/L Does not exclude early or localized gallbladder inflammation.
Lichte leukocytose 11.1-15.0 × 10⁹/L Supports inflammation when symptoms and examination fit.
Sterke leukocytose 15.1-18.0 × 10⁹/L Needs prompt assessment for complicated infection or another source.
Zeer hoog WBC >18.0 × 10⁹/L Can accompany severe cholecystitis; assess urgently with vital signs and imaging.

CRP, ESR, and why inflammation markers lag behind pain

CRP often rises 6-12 hours after an inflammatory trigger and peaks about 36-50 hours later, so an early normal CRP can be misleading. CRP is reported as mg/L in most countries; values under 5 mg/L are commonly considered normal in healthy adults.

Cholecystitis blood test laboratory assay showing CRP measurement in a clinical analyzer
Figuur 3: CRP timing explains why early pain can precede an abnormal inflammatory result.

In suspected cholecystitis, CRP boven 30 mg/L makes active tissue response more plausible, while values above 100 mg/L deserve careful assessment for more extensive inflammation, gangrenous change, perforation, or another infection. No single CRP cutoff reliably separates these conditions, which is why clinicians use a trend and the bedside examination.

ESR changes more slowly than CRP and is rarely useful for deciding whether tonight’s upper-abdominal pain needs imaging. A CRP of 8 mg/L after only 3 hours of symptoms tells me very little; repeating the clinical assessment matters more than repeating the marker at a fixed clock time.

A high-sensitivity CRP test designed for cardiovascular risk should not be used to judge acute abdominal illness. For context on assay purpose and common non-gallbladder causes, see our review of the CRP-albumineratio.

Cholecystitis liver enzyme results: the patterns that matter

Uncomplicated cystic-duct obstruction may leave ALT, AST, ALP, and bilirubin normal. A mixed or cholestatic liver pattern instead raises the possibility that a stone has entered or compressed the common bile duct.

Cholecystitis blood test showing liver enzyme pathway between gallbladder and bile ducts
Figuur 4: Different enzyme patterns help distinguish gallbladder inflammation from duct obstruction.

ALT en AST are intracellular enzymes, not direct measures of bile flow. An ALT of 180 U/L and AST of 140 U/L can occur after transient common-duct obstruction, sometimes before ALP rises; a sharp early spike may fall rapidly within 24-48 hours if the stone passes.

ALP en GGT generally rise more gradually in cholestasis because they reflect enzyme induction at the bile canaliculi and duct epithelium. An isolated ALP of 160 U/L is not enough to diagnose obstruction because bone turnover, pregnancy, recent fracture, and some medicines can also raise ALP.

Dr. Thomas Klein’s practical rule is to compare the direction and timing of all four markers, not to chase one enzyme. Our afkortingenhandleiding voor leveronderzoeken en uitleg van high ALT results can help you prepare better questions for the treating clinician.

Transaminasen Usually <35-45 U/L Normal results do not rule out cystic-duct obstruction.
Lichte stijging van ALT of AST 1-3 × bovengrens Can occur with transient stone passage, fatty liver, medicines, or viral illness.
Cholestatisch patroon ALP/GGT elevated with direct bilirubin rise Prompts assessment for common-duct obstruction.
Marked hepatocellular injury ALT or AST >500 U/L Needs urgent assessment for obstruction, hepatitis, ischemia, or drug injury.

Bilirubin results that suggest a bile-duct stone

A rising direct bilirubin with elevated ALP and GGT is more concerning for common-bile-duct obstruction than for isolated cholecystitis. Total bilirubin is commonly below 20 µmol/L (1.2 mg/dL), although laboratories set their own limits.

Cholecystitis blood test illustration of bilirubin movement through gallbladder and bile ducts
Figuur 5: Direct bilirubin rises when conjugated bile cannot drain normally.

Bilirubin becomes conjugated (direct) in the liver and is normally excreted into bile. When a duct stone blocks that route, conjugated bilirubin can spill back into circulation and darken urine; a total bilirubin of 45 µmol/L with a substantial direct fraction deserves timely imaging and clinical review.

Mild bilirubin elevation alone is surprisingly nonspecific. Fasting, dehydration, and Gilbert syndrome may raise unconjugated bilirubin, often below 50 µmol/L, without a blocked duct; that is a different biochemical story from jaundice plus pale stools, dark urine, and an ALP rise.

A bilirubin result should always be split into total and direct fractions when obstruction is being considered. Read more about directe bilirubinepatronen and the clinical meaning of yellow skin and dark urine.

Why lipase and amylase are checked with gallbladder pain

Lipase is checked because a gallstone can obstruct near the pancreatic duct and cause acute pancreatitis, which needs a different management pathway. Acute pancreatitis is typically supported by lipase at least three times the assay’s upper reference limit plus characteristic pain or imaging.

Cholecystitis blood test scene showing pancreatic lipase assay beside gallbladder anatomy
Figuur 6: Lipase helps identify gallstone-related pancreatic involvement during biliary pain.

A lipase of 420 U/L is meaningful only against that laboratory’s upper limit; if the limit is 60 U/L, it is seven times upper limit and strongly supports pancreatitis in the right clinical setting. Mild elevations below threefold occur with kidney impairment, bowel disease, medicines, and sometimes cholecystitis itself.

Amylase is less specific and may normalize sooner than lipase. Normal lipase does not settle every abdominal-pain diagnosis, but it makes established acute pancreatitis less likely when symptoms have been present for more than a day.

I advise patients not to interpret a lipase result as a gallbladder test. The distinction is detailed in our guide to high lipase urgency and our discussion of normal pancreatic enzymes despite pain.

Why normal gallbladder inflammation blood tests do not rule it out

Normal WBC, CRP, liver enzymes, and bilirubin do not exclude acute cholecystitis because the gallbladder can be obstructed locally before systemic markers change. This is particularly true in the first 6-12 uur and in people with a reduced immune response.

Cholecystitis blood test comparison of normal laboratory values and an obstructed gallbladder
Figuur 7: Local gallbladder obstruction can precede abnormal systemic laboratory markers.

The gallbladder’s cystic duct is separate from the common bile duct. A stone lodged only at the cystic duct can create distension and severe pain without raising bilirubin or ALP, while the liver continues to drain bile through the common duct.

People over 75, those with diabetes, and patients receiving corticosteroids may have fever below 38.0°C and a WBC below 11,0 × 10⁹/L despite clinically meaningful disease. The absence of classic findings lowers probability; it does not make the probability zero.

Kantesti AI is een AI lab test interpretatieservice that flags a normal panel as “not diagnostic” when the reported symptoms suggest an urgent structural problem. A laboratory reference interval means the value is statistically common in a comparison population, as explained in our article on what normal lab results can miss.

Other conditions and medicines that can mimic the laboratory pattern

Abnormal liver tests or inflammatory markers do not automatically come from the gallbladder. MASLD, viral hepatitis, alcohol exposure, medicines, urinary infection, pneumonia, and bowel inflammation can produce overlapping results.

Cholecystitis blood test differential showing liver cells, medication bottle and metabolic liver markers
Figuur 8: Several liver and systemic conditions can mimic a biliary laboratory pattern.

A stable ALT of 70 U/L over several years with normal bilirubin and ALP is more often compatible with metabolic dysfunction-associated steatotic liver disease than acute biliary obstruction. In contrast, a new ALT jump from 25 to 250 U/L during colicky pain warrants a search for a transient duct event.

Paracetamol overdose, antibiotics such as amoxicillin-clavulanate, anticonvulsants, and herbal products can cause liver-test abnormalities. Tell the clinician about every regular medicine and supplement, including “natural” products started within the last 90 dagen.

The useful question is what changed from your own baseline—not whether a result has a red flag. Our MASLD testing guide and discussion of medication-related lab trends show why timing changes the interpretation.

When ultrasound, HIDA scan, CT, or MRCP is needed

Ultrasound is the usual first imaging test for suspected cholecystitis, regardless of whether blood tests are normal or abnormal. It can show gallstones, gallbladder-wall thickening, surrounding fluid, distension, and focal tenderness when the probe is pressed over the gallbladder.

Cholecystitis blood test follow-up showing an abdominal ultrasound probe and gallbladder imaging
Figuur 9: Ultrasound tests the gallbladder structure that blood results cannot directly show.

A wall thickness above 3 mm, a distended gallbladder, pericholecystic fluid, and a sonographic Murphy sign support acute cholecystitis, though none is perfect in isolation. A stone plus compatible symptoms is often more decisive than a small liver-enzyme change.

When ultrasound is equivocal but suspicion remains high, clinicians may order a HIDA scan to assess cystic-duct patency. MRCP is especially useful when bilirubin or cholestatic enzymes suggest a common-duct stone; CT is often chosen when complications or an alternative diagnosis are being considered.

The 2020 WSES guideline recommends combining clinical assessment, laboratory findings, and imaging rather than relying on any single test (Pisano et al., 2020). Our overview of cholestase bloedtestpatronen explains why MRCP becomes more relevant when ALP, GGT, and bilirubin rise together.

When gallbladder pain and blood-test results need urgent care

Seek urgent same-day assessment for right-upper-abdominal pain lasting more than 6 hours, fever, repeated vomiting, jaundice, faintness, confusion, or a rigid abdomen—even with normal blood results. These features matter more than a single reassuring number.

Cholecystitis blood test urgent care pathway with clinical monitoring and abdominal assessment
Figuur 10: Persistent pain and systemic warning signs require assessment beyond laboratory results.

Een temperatuur van 38,0°C of hoger, pulse persistently above 100 beats/minute, low blood pressure, or new confusion can signal systemic illness. Jaundice plus fever and upper-abdominal pain is particularly concerning for cholangitis, a bile-duct infection that requires urgent hospital assessment.

Avoid eating or drinking if a clinician has advised emergency assessment, because surgery or a procedure may be needed. Do not use repeated high-dose pain medicines to “test” whether symptoms settle; NSAIDs and paracetamol have safe-dose limits and can complicate kidney or liver injury.

Sepsis cannot be diagnosed from WBC alone: a normal count occurs in some serious infections. If you are unsure whether symptoms cross the threshold, our sepsis laboratory warning guide outlines why vital signs and mental state are equally important.

Pregnancy, older age, diabetes, and other atypical presentations

Pregnancy, older age, diabetes, and immunosuppression can alter both symptoms and cholecystitis blood-test patterns. These groups deserve a lower threshold for in-person assessment because fever and leukocytosis may be muted or delayed.

Cholecystitis blood test clinical review showing diverse patient hands and pregnancy-safe laboratory assessment
Figuur 11: Special populations may need imaging despite subtle symptoms or laboratory changes.

During pregnancy, ALP can rise because the placenta produces the enzyme, so ALP is less useful for diagnosing bile obstruction. A direct bilirubin rise, new itching, jaundice, or right-upper-abdominal pain needs prompt obstetric and medical review; bile acids are a different test used for pregnancy-related cholestasis.

In older adults, reduced pain sensitivity, cognitive impairment, and dehydration can mask the classic symptom sequence. A modest CRP of 25 mg/L paired with functional decline or new confusion may be clinically more significant than the same CRP in a well 30-year-old.

People with diabetes can develop more severe gallbladder disease with fewer warning symptoms, although the evidence does not support assuming every diabetic patient has an atypical presentation. Our article on bile acids in pregnancy separates pregnancy itching from a gallbladder emergency.

How to make your laboratory results useful at the appointment

Bring the complete report, symptom timeline, medication list, and previous liver tests; the trend is often more informative than one result. A clinician can make better decisions when the onset of pain is linked to the time each sample was collected.

Cholecystitis blood test preparation with a patient organizing laboratory results and symptom timeline
Figuur 12: A timed symptom and laboratory history improves interpretation of biliary results.

Write down whether pain began suddenly, whether it followed food, where it travels, and whether it lasted 30 minutes, 4 hours, or overnight. Note vomiting, fever measurements, stool colour, urine colour, pregnancy possibility, recent travel, and the exact time you last ate.

Ask whether your panel included direct bilirubin, GGT, lipase, and a differential WBC count. A basic metabolic panel alone does not include these tests; it primarily measures electrolytes, glucose, calcium, and kidney markers.

Kantesti can organize a photographed report into a readable trend, but it cannot replace an examination or ultrasound when biliary pain is active. Our dark-urine assessment guide En blood-test timeline checklist may help you record details clinicians commonly need.

Waar AI-interpretatie helpt—en waar het moet stoppen

AI can identify a concerning combination such as rising bilirubin, ALP, GGT, and neutrophils, but it cannot confirm cholecystitis from a laboratory PDF. Gallbladder inflammation is a diagnosis that requires symptoms, examination, and usually imaging.

Cholecystitis blood test AI interpretation showing laboratory pattern review beside gallbladder imaging
Figuur 13: AI can organize laboratory patterns but cannot replace diagnostic imaging.

Kantesti is een AI-biomarkerinterpretatieplatform that compares laboratory values with the issuing laboratory’s ranges and with prior results when supplied. A rapid rise in total bilirubin from 12 to 48 µmol/L is clinically more actionable than two isolated values without dates.

Our system should be used as a question generator: “Could this be cholestasis?”, “Was direct bilirubin measured?”, and “Do I need urgent imaging?” It should never be used to delay urgent care for fever, jaundice, persistent pain, or vomiting.

Dr. Thomas Klein reviews these cases with a simple safety principle: a plausible explanation for a blood result is not the same thing as a diagnosis. Readers interested in how our safeguards work can review our klinische validatie-aanpak en de gids met 15.000+ biomarkers.

A practical next-step plan after a suspected biliary episode

If symptoms have resolved and there are no warning signs, arrange timely clinical follow-up; if pain persists or red flags appear, seek urgent assessment rather than waiting for repeat blood work. Repeat testing is useful only when it changes a real clinical decision.

Cholecystitis blood test follow-up plan with gallbladder imaging referral and organized lab results
Figuur 14: Follow-up combines symptom recurrence, repeat trends, imaging, and clinician review.

For a resolved episode with normal vital signs, clinicians may repeat CBC, CRP, bilirubin, ALT, AST, ALP, and GGT within 24-72 uur if the initial draw was early or abnormal. The interval should be individualized; a repeat panel is not a substitute for ultrasound when symptoms recur.

Until reviewed, avoid very large fatty meals if they consistently trigger pain, stay hydrated, and keep a brief record of episodes. Diet changes may reduce symptom provocation, but they do not dissolve an impacted stone or treat a bacterial complication.

Our medical team encourages readers to use laboratory interpretation as preparation for—not replacement of—care. The Medische Adviesraad provides oversight for Kantesti’s clinical education, while our technologiegids explains the boundaries of automated pattern analysis.

Veelgestelde vragen

Kan je cholecystitis hebben met normale bloedtesten?

Ja. Acute cholecystitis kan optreden met een normale WBC, CRP, bilirubine en leverenzymen, met name binnen de eerste 6-12 uur na het begin van de pijn of wanneer een steen alleen de ductus cysticus blokkeert. Een normale WBC onder de 11,0 × 10⁹/L verkleint de waarschijnlijkheid van een sterke systemische reactie, maar toont niet aan dat de galblaas normaal is. Aanhoudende pijn in het rechterbovenste deel van de buik, koorts, braken of lokale gevoeligheid rechtvaardigen nog steeds een klinische beoordeling en meestal een echografie.

Wat is een normale WBC-telling bij cholecystitis?

Een WBC-telling van meer dan ongeveer 11,0 × 10⁹/L, vaak met neutrofilie, kan acute cholecystitis ondersteunen wanneer de symptomen passen. Tellingen van 12-15 × 10⁹/L komen vaak voor bij ongecompliceerde inflammatoire presentaties, terwijl een WBC van meer dan 18 × 10⁹/L reden tot zorg kan geven voor ernstigere ziekte of een andere ernstige infectie. WBC is niet-specifiek, dus het kan galblaasontsteking niet onderscheiden van vele andere infecties of inflammatoire aandoeningen.

Stijgen leverenzymen bij een ontstoken galblaas?

Leverenzymen kunnen normaal blijven bij ongecompliceerde cholecystitis omdat de obstructie van de ductus cysticus de leverafvoer niet noodzakelijkerwijs blokkeert. ALT en AST kunnen transiënt stijgen wanneer een steen door de ductus choledochus gaat, terwijl ALP, GGT en directe bilirubine meer wijzen op een voortdurende galwegobstructie. ALT of AST boven 500 U/L vereist een spoedbeoordeling omdat de differentiële diagnose verder gaat dan galblaasziekte.

Welk bilirubineniveau suggereert een geblokkeerde galweg?

Er is geen enkele bilirubinedrempel die een verstopte galweg bewijst, maar een stijgend totaal bilirubine boven de laboratoriumbovengrens — vaak boven 20 µmol/L of 1,2 mg/dL — in combinatie met hoog direct bilirubine, hoge ALP en hoge GGT verhoogt de bezorgdheid. Een totaal bilirubine van ongeveer 45 µmol/L met geelzucht, donkere urine, koorts of pijn in de bovenbuik vereist onmiddellijke medische beoordeling. Geïsoleerde milde ongeconjugeerde bilirubineverhoging kan optreden bij vasten of het Gilbert-syndroom en heeft een andere betekenis.

Moet ik naar de spoedeisende hulp gaan als mijn bloedonderzoek voor de galblaas normaal is?

Ja, als de pijn langer dan 6 uur aanhoudt, u koorts heeft van 38,0 °C of hoger, herhaaldelijk braakt, geelzucht heeft, flauwvalt, verward bent of toenemende gevoeligheid van de buikwand heeft. Deze waarschuwingssignalen kunnen duiden op cholecystitis, cholangitis, pancreatitis of een andere acute abdominale aandoening, zelfs wanneer de initiële WBC- en levertests normaal zijn. Clinici in spoedeisende hulp gebruiken vitale functies, lichamelijk onderzoek, herhaald testen en beeldvorming in plaats van te vertrouwen op een enkel laboratoriumonderzoek.

Is CRP 100 mg/L high for cholecystitis?

A CRP of 100 mg/L is substantially elevated and indicates a significant inflammatory response, but it does not identify the source by itself. In a person with compatible right-upper-abdominal pain, fever, and ultrasound findings, CRP above 100 mg/L should increase concern for more extensive gallbladder inflammation or a complication. CRP can also reach this range with pneumonia, kidney infection, bowel inflammation, and many other conditions, so urgent clinical context is required.

Ontvang vandaag nog AI-aangedreven bloedtestanalyse

Sluit je aan bij meer dan 2 miljoen gebruikers wereldwijd die Kantesti vertrouwen voor directe, nauwkeurige analyse van labtests. Upload je bloedwaarden resultaten en ontvang binnen enkele seconden een uitgebreide interpretatie van 15,000+-biomarkers.

📚 Geraadpleegde wetenschappelijke publicaties

1

Klein, T., Mitchell, S., & Weber, H. (2026). Een vooraf geregistreerde, op rubrics gebaseerde geautomatiseerde technische benchmark van de Kantesti-bloedtestinterpretatie-engine op 100.000 synthetische testcases. Kantesti AI medisch onderzoek.

2

Klein, T., Mitchell, S., & Weber, H. (2026). Klinisch validatiekader v2.0 (Medische validatiepagina). Kantesti AI medisch onderzoek.

📖 Externe medische referenties

3

Yokoe M et al. (2018). Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). Journal of Hepato-Biliary-Pancreatic Sciences.

4

Pisano M et al. (2020). 2020 World Society of Emergency Surgery updated guidelines for the diagnosis and treatment of acute calculus cholecystitis. World Journal of Emergency Surgery.

2M+Geanalyseerde tests
127+Landen
75+Talen

⚕️ Medische disclaimer

E-E-A-T Vertrouwenssignalen

Ervaring

Klinische beoordeling door artsen van lab-interpretatieworkflows.

📋

Expertise

Laboratoriumgeneeskunde met focus op hoe biomarkers zich gedragen in een klinische context.

👤

Gezag

Geschreven door Dr. Thomas Klein, met review door Dr. Sarah Mitchell en Prof. Dr. Hans Weber.

🛡️

Betrouwbaarheid

Evidence-based interpretatie met duidelijke vervolgstappen om onrust te verminderen.

🏢 Kantesti LTD Geregistreerd in Engeland & Wales · Bedrijfsnummer. 17090423 Londen, Verenigd Koninkrijk · kantesti.net
blank
Door Prof. Dr. Thomas Klein

Dr. Thomas Klein is een door het bestuur gecertificeerde klinisch hematoloog en is Chief Medical Officer bij Kantesti AI. Met meer dan 15 jaar ervaring in laboratoriumgeneeskunde en een sterke interesse in door AI ondersteunde interpretatie van bloedwaarden resultaten, werkt hij aan het verbinden van nieuwe technologie met de dagelijkse klinische praktijk. Zijn aandachtsgebieden omvatten analyse van biomarkers, onderzoek naar klinische beslissingsondersteuning en optimalisatie van populatie-specifieke referentiewaarden. Als CMO levert hij klinische input voor de interne benchmarking van het platform en voorziet hij in klinisch toezicht op de medische kwaliteit van de educatieve rapporten van Kantesti.

Geef een reactie

Je e-mailadres wordt niet gepubliceerd. Vereiste velden zijn gemarkeerd met *